Last reviewed · How we verify

NCT05687539

Mastiha or Mastiha Water in Functional Dyspepsia

Completed NA Last updated 27 January 2025
What this trial tests

NA trial testing Mastiha water in Functional Dyspepsia in 48 participants. Completed in 30 September 2024.

Timeline
1 June 2022
Primary endpoint
30 September 2024
30 September 2024

Quick facts

Lead sponsorHarokopio University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposetreatment
Enrollment48
Start date1 June 2022
Primary completion30 September 2024
Estimated completion30 September 2024
Sites1 location across Greece

Drugs / interventions tested

Conditions studied

Sponsor

Harokopio University

Who can join

18 and older, any sex, with Functional Dyspepsia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main aim of this study is to establish whether Mastiha products ameliorate functional dyspepsia symptoms.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A randomized, three-way crossover clinical trial on the efficacy of Mastiha based therapies (Pistacia lentiscus var. Chia) in functional dyspepsia.
    Kleftaki SA, Amerikanou C, Tzavara C, Biagki T, et al · · 2025 · PMID 41197785 · DOI 10.1016/j.phrs.2025.108019

Verify or expand the search:

Other recruiting trials for Functional Dyspepsia

Currently open trials in the same condition.

Other Harokopio University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05687539.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing